Comparison

JIMT-1 cells

Item no. C0006005
Manufacturer Addexbio
Amount One Frozen vial
Category
Type Tumour Cells
Specific against Human
Dry ice Yes
Citations 1.Barok, M., Isola, J., Palyi-Krekk, Z., Nagy, P., Juhasz, I., Vereb, G., Kauraniemi, P., Kapanen, A., Tanner, M., Vereb, G., and Szollosi, J. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther, 6: 2065-2072, 2007.
2. McCluskey AJ, et al. Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol Oncol., Jun;7(3):440-51, 2013 PMID: 23290417
3. Andrew J, et al. Receptor-directed chimeric toxins created by sortase-mediated protein fusion. Mol Cancer Ther. Oct;12(10):2273-81, 2013 PMID: 23945077
4.Bhinder B, Shum D, Li M, Ibanez G, Vlassov AV, Magdaleno S, Djaballah H. Discovery of a dicer-independent, cell-type dependent alternate targeting sequence generator: implications in gene silencing & pooled RNAi screens. PLoS One. 2014 Jul 2;9(7):e100676. PMID: 24987961
5.Yeh ES, Abt MA, Hill EG. Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors. Breast Cancer Res Treat. 2015 Jan;149(1):91-98. PMID: 25515931
6.Colombo M, Fiandra L, Alessio G, Mazzucchelli S, Nebuloni M, De Palma C, Kantner K, Pelaz B, Rotem R, Corsi F, Parak WJ, Prosperi D. Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies. Nat Commun. 2016 Dec 19;7:13818. doi: 10.1038/ncomms13818. PMID: 27991503
7.Yeh ES, Williams CJ, Williams CB, Bonilla IV, Klauber-DeMore N, Phillips SL. Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration. Oncotarget. 2017 Nov 25;8(65):109358-109369. PMID: 29312613
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Available
Description

Disease:

Breast carcinoma

Origin:

Established from pleural effusions of a breast cancer patient (grade 3 invasive, T2N1M0)

Species:

Homo sapiens

Tissue:

Breast, mammary gland

Morphology:

Epithelial

Properties:

Adherent

Cytogenic data:

Human flat-moded highly rearranged hyperdiploid karyotype with 6% polyploidy - 46-56< 2n> XX, +1, +2, +2, +3, +5, +6, +7, +12, -13, -14, -15, -15, -16, -18, +17, +5mar, add(X)(p22.1), add(1)(q11), del(1)(q32.2), der(1)add(1)(p21)add(1)(q22), der(1)t(1; 6)(p11; q1?1)t(6; 5)(q25; ?p13), add(2)(q11)x2, t(2; 3)(q10; p10)add(2)(q25-31), add(3)(p11), der(4)t(?3; 4)(?q24; p11), add(5)(q15), der(5)add(5)(p15.3)del(5)(q22), der(5)t(5; 8)(p11; p11), add(6)(p11)add(6)(q23), der(7)t(1; 7)(p13; q21), der(7)t(7; ?12)(p11; p11), add(8)(p11), i(8q) add(9)(p11), der(9)add(9)(p11)add(9)(q23), add(11)(p13), der(11)dup(11)(p11p15)add(11)(p15), der(11)t(1; 11)(q24; p12), add(12)(q21), der(12; ?15)(p11; q11), add(17)(p11), add(17)(p13), der(17)add(17)(p11)add(17)(q21)

Patient:

Female, 62 yrs of age

Medium:

AddexBio-formulated DMEM (C0003-01) + 10% FBS

Subculture:

1:2 to 1:6 (80-90%); using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C

Freezing Medium:

Complete culture medium supplemented with 5% (v/v) DMSO

Biosafety Level:

I

Sterility:

Bacteria: Negative

Yeast: Negative

Mycoplasma: Negative

Pathogens:

HIV: Negative

Hepatitis B: Negative

Hepatitis C: Negative

Protein Expression:

cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin -

DNA Profile (STR):

Amelogenin: X, X

CSF1PO: 12, 13

D13S317: 8, 13

D16S539: 11, 11

D5S818: 12, 13, 14

D7S820: 12, 12

THO1: 7, 7

TPOX: 8, 8

vWA: 18, 18

Citation Format:

If use of this culture results in a scientific publication, it should be cited in the publication as: JIMT-1 (AddexBio C0006005)

Mutations in JIMT-1 Cells

Related cells by Organ:

4T1

AU-565

BT-20

BT-474

BT-483

BT-549

JIMT-1

MCF-7

SK-BR-3

T47D

ZR-75-1

Storage condition
LN2
Manufacturers Category
Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: One Frozen vial
Available: In stock
available

Delivery expected until 12/13/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close